| Value of information (VOI) is considered valuable to guide decisions on additional research and adoption concerning pharmaceuticals. |
| VOI is currently not common practice in research and decisions concerning pharmaceuticals. |
| Practical guidelines are needed that indicate how to perform VOI. |
| A threshold incremental cost-effectiveness ratio (ICER) should be defined to enable VOI results to be interpreted. |
| A policy framework is needed that includes criteria of when to perform VOI, agreements on how the results are being used and on who pays what amount for additional research. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.